Avanos Medical (AVNS) Liabilities from Discontinued Operations (2016 - 2024)
Avanos Medical's Liabilities from Discontinued Operations history spans 6 years, with the latest figure at 52900000.0 for Q3 2024.
- On a quarterly basis, Liabilities from Discontinued Operations rose 2016.0% to 52900000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was 52900000.0, a 2016.0% increase, with the full-year FY2023 number at 63700000.0, up 797.18% from a year prior.
- Liabilities from Discontinued Operations hit 52900000.0 in Q3 2024 for Avanos Medical, roughly flat from 52700000.0 in the prior quarter.
- Over the last five years, Liabilities from Discontinued Operations for AVNS hit a ceiling of 63700000.0 in Q4 2023 and a floor of 2500000.0 in Q3 2023.
- Historically, Liabilities from Discontinued Operations has averaged 38516666.67 across 3 years, with a median of 52450000.0 in 2024.
- Biggest five-year swings in Liabilities from Discontinued Operations: surged 797.18% in 2023 and later skyrocketed 2016.0% in 2024.
- Tracing AVNS's Liabilities from Discontinued Operations over 3 years: stood at 7100000.0 in 2022, then surged by 797.18% to 63700000.0 in 2023, then dropped by 16.95% to 52900000.0 in 2024.
- Business Quant data shows Liabilities from Discontinued Operations for AVNS at 52900000.0 in Q3 2024, 52700000.0 in Q2 2024, and 52200000.0 in Q1 2024.